ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $690,000 | -81.3% | 55,502 | -79.4% | 0.00% | -83.3% |
| Q3 2016 | $3,687,000 | +32.9% | 269,352 | -28.2% | 0.02% | +33.3% |
| Q2 2016 | $2,774,000 | +15.7% | 375,352 | 0.0% | 0.02% | +20.0% |
| Q1 2016 | $2,398,000 | +2.2% | 375,352 | 0.0% | 0.02% | +7.1% |
| Q4 2015 | $2,346,000 | +7.0% | 375,352 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $2,192,000 | -29.4% | 375,352 | 0.0% | 0.01% | -7.7% |
| Q2 2015 | $3,104,000 | +0.4% | 375,352 | 0.0% | 0.01% | +8.3% |
| Q1 2015 | $3,093,000 | +2.2% | 375,352 | -14.8% | 0.01% | +9.1% |
| Q4 2014 | $3,027,000 | +27.2% | 440,602 | 0.0% | 0.01% | +37.5% |
| Q3 2014 | $2,379,000 | -22.3% | 440,602 | -8.3% | 0.01% | -11.1% |
| Q2 2014 | $3,061,000 | -26.5% | 480,602 | -7.0% | 0.01% | -25.0% |
| Q1 2014 | $4,164,000 | -11.1% | 516,602 | -24.8% | 0.01% | -7.7% |
| Q4 2013 | $4,683,000 | – | 686,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |